
HealthEquity (HQY) Stock Forecast & Price Target
HealthEquity (HQY) Analyst Ratings
Bulls say
HealthEquity Inc. reported strong financial results for Q2/26, with total revenue increasing by 8.6% year-over-year to $325.8 million, driven primarily by a significant 15.3% growth in custodial revenue, which accounted for 49.1% of the total revenue. The company's health savings account (HSA) cash reached $17.035 billion, reflecting a 4% year-over-year increase, while HSA investments rose by an impressive 24% to $16.1 billion, showcasing robust growth in both account balances and investment participation. Additionally, interchange revenue grew by 8.0% to $48.1 million, supported by an increase in total accounts and higher spending per account, reinforcing the company's positive momentum in the consumer-directed benefits market.
Bears say
HealthEquity's stock is currently trading at multiples lower than both its high-growth SaaS peer group average and its own five-year valuation averages, indicating potential overvaluation amid a backdrop of declining performance with shares down 7% year-to-date. Additionally, while revenue forecasts for FY/27 remain stable, the adjusted EBITDA projection has been revised downward, highlighting concerns over profitability despite expected revenue growth. The company faces several risks, including increased competition, regulatory challenges, and economic factors such as falling interest rates, which could further impact its financial stability and market position.
This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.
HealthEquity (HQY) Analyst Forecast & Price Prediction
Start investing in HealthEquity (HQY)
Order type
Buy in
Order amount
Est. shares
0 shares